Syra Health Corp financial data

Symbol
SYRA on OTC
Location
1119 Keystone Way N., #201, Carmel, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 380 % +51.4%
Debt-to-equity 38.1 % -54.7%
Return On Equity -52.6 % +73.8%
Return On Assets -38.1 % +65.1%
Operating Margin -18.2 % +69.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.3M shares +71.5%
Weighted Average Number of Shares Outstanding, Basic 11.9M shares +80.8%
Weighted Average Number of Shares Outstanding, Diluted 11.9M shares +80.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.95M USD -1.19%
Revenue from Contract with Customer, Excluding Assessed Tax 8.06M USD +14.1%
Research and Development Expense 96.6K USD -89.3%
Operating Income (Loss) -1.47M USD +64.8%
Nonoperating Income (Expense) 9.28K USD -552%
Net Income (Loss) Attributable to Parent -1.46M USD +65.2%
Earnings Per Share, Basic 0 USD/shares +82.1%
Earnings Per Share, Diluted 0 USD/shares +82.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.31M USD
Accounts Receivable, after Allowance for Credit Loss, Current 886K USD
Other Assets, Current 242K USD -38%
Assets, Current 3.43M USD +21.5%
Property, Plant and Equipment, Net 14.6K USD -75.8%
Operating Lease, Right-of-Use Asset 22.2K USD -93.7%
Assets 3.47M USD +7.2%
Accounts Payable, Current 557K USD +11.4%
Accrued Liabilities, Current 125K USD -28.4%
Liabilities, Current 1.06M USD +17.3%
Operating Lease, Liability, Noncurrent 187K USD
Liabilities 1.06M USD -7.74%
Retained Earnings (Accumulated Deficit) -9.36M USD -18.4%
Stockholders' Equity Attributable to Parent 2.41M USD +15.4%
Liabilities and Equity 3.47M USD +7.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 158K USD
Net Cash Provided by (Used in) Financing Activities -63.1K USD -108%
Net Cash Provided by (Used in) Investing Activities -5.62K USD +41.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 95.2K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.31M USD +44.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.23K USD -20.8%
Deferred Tax Assets, Valuation Allowance 1.9M USD +84.6%
Deferred Tax Assets, Gross 1.9M USD +84.6%
Operating Lease, Liability 22.2K USD -93.7%
Depreciation 45.6K USD -16.5%
Payments to Acquire Property, Plant, and Equipment 5.62K USD -41.8%
Lessee, Operating Lease, Liability, to be Paid 336K USD +423%
Operating Lease, Liability, Current 22.2K USD -79.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 135K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 135K USD +109%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 37.1K USD +3384%
Lessee, Operating Lease, Liability, to be Paid, Year Three 67.3K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.8M USD +17.8%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 3.23K USD -20.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%